We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
Highlights of Vol 4 | Issue 7 | 2026
The present study focuses on the formulation and evaluation of mucoadhesive buccal films of Tramadol hydrochloride for effective pain management. The objective was to dev...
Neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and brain tumors remain major global health challenges due to the difficulty of del...
Hypothyroidism is a common endocrine disorder characterized by inadequate secretion of thyroid hormones, leading to metabolic dysfunction and multisystem involvement. Cla...
The present study aimed to develop and validate a simple, precise, accurate, robust, and economical reverse-phase high-performance liquid chromatographic (RP-HPLC) method...
The present study was aimed at the development and validation of a simple, precise, accurate, rapid, and economical Reverse Phase High Performance Liquid Chromatographic ...
Nanosuspension terms divided into two words “Nano” and “suspension”. Nano refers to the particle size in the range of nanometres. Which is usually below 1000nm. W...
Psoriasis is a chronic inflammatory skin disease caused by a complex interaction between genetic susceptibility, environmental factors, and immune dysregulation. It is ch...
Loxapine succinate is a dibenzoxazepine antipsychotic agent widely used in the management of schizophrenia and acute agitation. Owing to its therapeutic importance and po...
Quality by Design (QbD) has become the dominant framework for developing stability-indicating analytical methods for pharmaceutical dosage forms, replacing empirical one-...
Background: Oral disintegrating and dispersible tablet technologies rely heavily on the choice of disintegrant to achieve rapid tablet breakup, fast dissolution, and impr...
Background: Atypical antipsychotic drugs used in the management of schizophrenia and bipolar disorder are frequently associated with poor patient adherence, in part due t...
Background: Ubrogepant and rimegepant are second-generation, orally administered calcitonin gene-related peptide (CGRP) receptor antagonists ("gepants") approved for the ...